Evidence map›Paper›PMID 36564707›Full record

ArticleBMC microbiology2022

Analysis of gut microbiota diversity in Hashimoto's thyroiditis patients.

Jilai Liu, Xuejun Qin, Boxi Lin, Jing Cui, Juan Liao, Fu Zhang, Qing Lin

Open access · goldAbstract read
In one paragraph

Article in BMC microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Gut Microbiota and Thyroid Diseases.The Eurasian journal of medicine · 2026
    Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Jilai LiuDepartment of Clinical Laboratory, People's Hospital Affiliated of Fujian University of Traditional Chinese Medicine, Fuzhou, 350004, China.
Xuejun QinDepartment of Clinical Laboratory, People's Hospital Affiliated of Fujian University of Traditional Chinese Medicine, Fuzhou, 350004, China.
Boxi LinDepartment of Clinical Laboratory, People's Hospital Affiliated of Fujian University of Traditional Chinese Medicine, Fuzhou, 350004, China.
Jing CuiDepartment of Clinical Laboratory, People's Hospital Affiliated of Fujian University of Traditional Chinese Medicine, Fuzhou, 350004, China.
Juan LiaoDepartment of Clinical Laboratory, People's Hospital Affiliated of Fujian University of Traditional Chinese Medicine, Fuzhou, 350004, China.
Fu ZhangDepartment of Clinical Laboratory, People's Hospital Affiliated of Fujian University of Traditional Chinese Medicine, Fuzhou, 350004, China. 22581605@qq.com.
Qing LinDepartment of Clinical Laboratory, People's Hospital Affiliated of Fujian University of Traditional Chinese Medicine, Fuzhou, 350004, China. fjlinqing@126.com.
Fujian University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHashimoto's thyroiditis (HT) is an autoimmune disease. Recent studies have found that the gut microbiota may play an important role in inducing HT, but there are no systematic studies on the changes in the gut microbiota during the development of HT.

methodsIn this study, 16S rDNA high-throughput sequencing technology in combination with the Kruskal-Wallis test, CCA/RDA analysis, Spearman correlation analysis, and other statistical methods were used to analyze the effects of age, gender, hormones, and other environmental factors on gut microbiota by comparing the differences in the microbiota at different stages of HT development.

resultsThe results showed that there were differences in the gut microbiota composition between healthy people (HCA) and in patients with HT. Lachnoclostridium, Bilophila, and Klebsiella were enriched in the HCA group, while Akkermansia, Lachnospiraceae, Bifidobacterium, Shuttleia, and Clostriworthdia were enriched in the HT group. Environmental factors analysis revealed that the Bifidobacterium and Klebsiella were two groups of bacteria that have undergone dramatic changes in HCA and HT, and mainly affected by gender. Romboutsia and Haemophilus regulated by the hormone of free triiodothyronine (FT3) may promote the development of HT, while Faecalibacterium and Lachnospiraceae regulated by free thyroxine (FT4) may protect the host.

conclusionsComprehensive studies have shown that gender is an important factor affecting gut microbial composition, but with the development of HT, hormones, age, and TSH begin to become dominant factors.

Indexed as

Gastrointestinal MicrobiomeHashimoto DiseaseHormonesHumansHormones16S rDNABiomarkersGut microbiotaHashimoto’s thyroiditisHigh-throughput sequencing

Identifiers

PMID36564707
PMCPMC9789560
OpenAlexW4312203412

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.